Literature DB >> 28750825

Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis).

Deepak K Gupta1, Lori B Daniels2, Susan Cheng3, Christopher R deFilippi4, Michael H Criqui5, Alan S Maisel6, Joao A Lima7, Hossein Bahrami8, Philip Greenland9, Mary Cushman10, Russell Tracy11, David Siscovick12, Alain G Bertoni13, Valentina Cannone14, John C Burnett14, John Jeffrey Carr15, Thomas J Wang16.   

Abstract

Natriuretic peptides (NP) are cardiac-derived hormones with favorable cardiometabolic actions. Low NP levels are associated with increased risks of hypertension and diabetes mellitus, conditions with variable prevalence by race and ethnicity. Heritable factors underlie a significant proportion of the interindividual variation in NP concentrations, but the specific influences of race and ancestry are unknown. In 5597 individuals (40% white, 24% black, 23% Hispanic, and 13% Chinese) without prevalent cardiovascular disease at baseline in the Multi-Ethnic Study of Atherosclerosis, multivariable linear regression and restricted cubic splines were used to estimate differences in serum N-terminal pro B-type natriuretic peptide (NT-proBNP) levels according to, ethnicity, and ancestry. Ancestry was determined using genetic ancestry informative markers. NT-proBNP concentrations differed significantly by race and ethnicity (black, median 43 pg/ml [interquartile range 17 to 94], Chinese 43 [17 to 90], Hispanic 53 [23 to 107], white 68 [34 to 136]; p = 0.0001). In multivariable models, NT-proBNP was 44% lower (95% confidence interval -48 to -40) in black and 46% lower (-50 to -41) in Chinese, compared with white individuals. Hispanic individuals had intermediate concentrations. Self-identified blacks and Hispanics were the most genetically admixed. Among self-identified black individuals, a 20% increase in genetic European ancestry was associated with 12% higher (1% to 23%) NT-proBNP. Among Hispanic individuals, genetic European and African ancestry were positively and negatively associated with NT-proBNP levels, respectively. In conclusion, NT-proBNP levels differ according to race and ethnicity, with the lowest concentrations in black and Chinese individuals. Racial and ethnic differences in NT-proBNP may have a genetic basis, with European and African ancestry associated with higher and lower NT-proBNP concentrations, respectively.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28750825      PMCID: PMC5575954          DOI: 10.1016/j.amjcard.2017.06.030

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  Association between human atrial natriuretic peptide Val7Met polymorphism and baseline blood pressure, plasma trough irbesartan concentrations, and the antihypertensive efficacy of irbesartan in rural Chinese patients with essential hypertension.

Authors:  Shanchun Zhang; Guangyun Mao; Yan Zhang; Genfu Tang; Yufeng Wen; Xiumei Hong; Shanqun Jiang; Yunxian Yu; Xiping Xu
Journal:  Clin Ther       Date:  2005-11       Impact factor: 3.393

2.  Changes in N-terminal pro-B-type natriuretic peptide and incidence of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  O A Sanchez; D A Duprez; H Bahrami; C A Peralta; L B Daniels; J A Lima; A Maisel; A R Folsom; D R Jacobs
Journal:  Diabetes Metab       Date:  2015-06-03       Impact factor: 6.041

3.  Racial Differences in Natriuretic Peptide Levels: The Dallas Heart Study.

Authors:  Deepak K Gupta; James A de Lemos; Colby R Ayers; Jarett D Berry; Thomas J Wang
Journal:  JACC Heart Fail       Date:  2015-06-10       Impact factor: 12.035

4.  Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians.

Authors:  Norihiro Kato; Fumihiko Takeuchi; Yasuharu Tabara; Tanika N Kelly; Min Jin Go; Xueling Sim; Wan Ting Tay; Chien-Hsiun Chen; Yi Zhang; Ken Yamamoto; Tomohiro Katsuya; Mitsuhiro Yokota; Young Jin Kim; Rick Twee Hee Ong; Toru Nabika; Dongfeng Gu; Li-Ching Chang; Yoshihiro Kokubo; Wei Huang; Keizo Ohnaka; Yukio Yamori; Eitaro Nakashima; Cashell E Jaquish; Jong-Young Lee; Mark Seielstad; Masato Isono; James E Hixson; Yuan-Tsong Chen; Tetsuro Miki; Xueya Zhou; Takao Sugiyama; Jae-Pil Jeon; Jian Jun Liu; Ryoichi Takayanagi; Sung Soo Kim; Tin Aung; Yun Ju Sung; Xuegong Zhang; Tien Yin Wong; Bok-Ghee Han; Shotai Kobayashi; Toshio Ogihara; Dingliang Zhu; Naoharu Iwai; Jer-Yuarn Wu; Yik Ying Teo; E Shyong Tai; Yoon Shin Cho; Jiang He
Journal:  Nat Genet       Date:  2011-05-15       Impact factor: 38.330

5.  Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension.

Authors:  Daniel L Dries; Ronald G Victor; J Eduardo Rame; Richard S Cooper; Xiaodong Wu; Xiaofeng Zhu; David Leonard; Su-Inn Ho; Qingyu Wu; Wendy Post; Mark H Drazner
Journal:  Circulation       Date:  2005-10-10       Impact factor: 29.690

6.  N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis.

Authors:  Eui-Young Choi; Hossein Bahrami; Colin O Wu; Philip Greenland; Mary Cushman; Lori B Daniels; Andre L C Almeida; Kihei Yoneyama; Anders Opdahl; Aditya Jain; Michael H Criqui; David Siscovick; Christine Darwin; Alan Maisel; David A Bluemke; Joao A C Lima
Journal:  Circ Heart Fail       Date:  2012-10-02       Impact factor: 8.790

7.  Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.

Authors:  Christopher Newton-Cheh; Martin G Larson; Ramachandran S Vasan; Daniel Levy; Kenneth D Bloch; Aarti Surti; Candace Guiducci; Sekar Kathiresan; Emelia J Benjamin; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Stefan Blankenberg; Frank Kee; Peter Nilsson; Xiaoyan Yin; Leena Peltonen; Erkki Vartiainen; Veikko Salomaa; Joel N Hirschhorn; Olle Melander; Thomas J Wang
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

8.  Comparing self-reported ethnicity to genetic background measures in the context of the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Jasmin Divers; David T Redden; Kenneth M Rice; Laura K Vaughan; Miguel A Padilla; David B Allison; David A Bluemke; Hunter J Young; Donna K Arnett
Journal:  BMC Genet       Date:  2011-03-04       Impact factor: 2.797

9.  Impact of obesity on plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

10.  Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension.

Authors:  S W John; J H Krege; P M Oliver; J R Hagaman; J B Hodgin; S C Pang; T G Flynn; O Smithies
Journal:  Science       Date:  1995-02-03       Impact factor: 47.728

View more
  21 in total

1.  Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS.

Authors:  Nirav Patel; Mary Cushman; Orlando M Gutiérrez; George Howard; Monika M Safford; Paul Muntner; Raegan W Durant; Sumanth D Prabhu; Garima Arora; Emily B Levitan; Pankaj Arora
Journal:  JCI Insight       Date:  2019-06-04

2.  NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Sushan Yang; Shi Huang; Lori B Daniels; Joseph Yeboah; Joao A C Lima; Valentina Cannone; John C Burnett; Joshua A Beckman; J Jeffrey Carr; Thomas J Wang; Deepak K Gupta
Journal:  Heart       Date:  2019-05-31       Impact factor: 5.994

3.  Association of African Ancestry With Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study.

Authors:  Aya J Alame; Sonia Garg; Julia Kozlitina; Colby Ayers; Ronald M Peshock; Susan A Matulevicius; Mark H Drazner
Journal:  JAMA Cardiol       Date:  2018-12-01       Impact factor: 14.676

4.  Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study.

Authors:  Alana A Lewis; Colby R Ayers; Elizabeth Selvin; Ian Neeland; Christie M Ballantyne; Vijay Nambi; Ambarish Pandey; Tiffany M Powell-Wiley; Mark H Drazner; Mercedes R Carnethon; Jarett D Berry; Stephen L Seliger; Christopher R DeFilippi; James A de Lemos
Journal:  Circulation       Date:  2020-01-14       Impact factor: 29.690

5.  Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide.

Authors:  Nirav Patel; Orlando M Gutiérrez; Garima Arora; George Howard; Virginia J Howard; Suzanne E Judd; Sumanth D Prabhu; Emily B Levitan; Mary Cushman; Pankaj Arora
Journal:  Int J Cardiol       Date:  2019-02-21       Impact factor: 4.164

6.  Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Mark Ainslie; Virginia Mplani; Georgia Karavasili; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-11-28       Impact factor: 3.327

7.  Race, Natriuretic Peptides, and High-Carbohydrate Challenge: A Clinical Trial.

Authors:  Nirav Patel; Griffin K Russell; Kiran Musunuru; Orlando M Gutierrez; Ganesh Halade; Vasundhara Kain; Wenjian Lv; Sumanth D Prabhu; Kenneth B Margulies; Thomas P Cappola; Garima Arora; Thomas J Wang; Pankaj Arora
Journal:  Circ Res       Date:  2019-10-06       Impact factor: 17.367

8.  Understanding the Complexity of Heart Failure Risk and Treatment in Black Patients.

Authors:  Aditi Nayak; Albert J Hicks; Alanna A Morris
Journal:  Circ Heart Fail       Date:  2020-08-13       Impact factor: 8.790

9.  B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure.

Authors:  Michelle K York; Deepak K Gupta; Cassandra F Reynolds; Eric Farber-Eger; Quinn S Wells; Katherine N Bachmann; Meng Xu; Frank E Harrell; Thomas J Wang
Journal:  J Am Coll Cardiol       Date:  2018-05-15       Impact factor: 24.094

10.  Racial Differences in Atrial Cardiopathy Phenotypes in Ischemic Stroke Patients.

Authors:  Hooman Kamel; Kathleen Alwell; Brett M Kissela; Heidi J Sucharew; Daniel Woo; Matthew Flaherty; Simona Ferioli; Stacie L Demel; Charles J Moomaw; Kyle Walsh; Jason Mackey; De Los Rios La Rosa Felipe; Adam Jasne; Sabreena Slavin; Sharyl Martini; Opeolu Adeoye; Tehniyat Baig; Monica L Chen; Emily B Levitan; Elsayed Z Soliman; Dawn O Kleindorfer
Journal:  Neurology       Date:  2020-11-25       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.